A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety and Efficacy of Carvedilol Versus Placebo in the Treatment of Post Traumatic Stress Disorder.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Carvedilol (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 07 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Oct 2010 New trial record